etrasimod (APD334) - Arena
Etrasimod: Data from P3 trial for Crohn's disease in 2022 (Arena) - Jan 16, 2020 - Corporate Presentation 
P3 data
http://invest.arenapharm.com/events-presentations
 
Jan 16, 2020
 
 
ef70b9f5-29b8-4aae-8eb3-b6cb6f92800c.jpg